When blood cancer in children progresses particularly aggressively, it is often due to a genetic defect: a gene fusion, such ...
A research team led by Park Hyun-woo, a biochemistry professor at Yonsei University, has introduced a pioneering method in ...
Triple-negative breast cancer (TNBC) is one of the most aggressive and treatment-resistant forms of breast cancer. It grows ...
Cells frequently encounter conditions that can damage them or even lead to cell death. To keep functioning, they must rapidly ...
The protein, reverse transcriptase, has become an essential tool for making DNA copies of RNA.
3don MSN
From lab to clinic: Phase I trial of promising combination therapy for resistant ovarian cancer
Researchers at the University of Colorado Cancer Center have discovered a novel therapy combination that could offer new hope ...
Findings set the stage for further investigation of hSFRP2 mAb as a targeted therapy for triple-negative breast cancer.
The mammalian elongation complex has remained a mystery – until researchers discovered how it controls its speed.
News-Medical.Net on MSN
Novel antibody suppresses primary tumor growth and spread of triple-negative breast cancer
Triple-negative breast cancer (TNBC) is one of the most aggressive and treatment-resistant forms of breast cancer. It grows ...
A Northwestern Medicine study published in the Journal of Clinical Investigation has uncovered a connection between a ...
Learn how Ignota Labs is addressing drug toxicity challenges through AI, aiming to revive effective yet shelved drugs.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results